Target intelligence / Profile preview

Globin gene (HBB/HBA)

Target
HBB/HBA
Molecular classification
Oxygen-binding protein, Globin family, Intracellular protein
01

Overview

The globin genes comprise two main clusters, the alpha-globin cluster on chromosome 16 and the beta-globin cluster on chromosome 11, which encode the protein subunits of hemoglobin. Hemoglobin is the primary metalloprotein in red blood cells responsible for transporting oxygen from the lungs to peripheral tissues and returning carbon dioxide (Source: UniProt, NIH). During human development, these genes undergo a tightly regulated switching process from embryonic to fetal (HbF) and finally to adult (HbA) hemoglobin. Mutations in these genes, particularly the HBB gene, lead to prevalent genetic disorders known as hemoglobinopathies, including sickle cell disease and beta-thalassemia, which cause chronic anemia and multi-organ damage (Source: StatPearls). Therapeutic interventions target these genes through various modalities to restore functional hemoglobin levels. Small molecules like hydroxyurea induce the expression of fetal globin to compensate for defective adult forms, while novel gene therapies utilize lentiviral vectors to add functional genes or CRISPR-based editing to silence repressors like BCL11A, thereby restoring healthy hemoglobin production (Source: FDA, Nature Reviews).

Other names
Hemoglobin geneHBBHBA1HBA2HBG1HBG2HBDHBE1Beta-globin locusAlpha-globin locus
02

Mechanism of action

Induction of fetal hemoglobin (HbF) expression; Allosteric stabilization of the oxygenated state of hemoglobin; Lentiviral-mediated gene addition of functional globin; CRISPR-Cas9 disruption of the BCL11A erythroid-specific enhancer to reactivate gamma-globin expression.

03

Biological functions

Oxygen transportCarbon dioxide transportNitric oxide homeostasispH bufferingErythropoiesis
04

Disease associations

Sickle cell diseaseBeta-thalassemiaAlpha-thalassemiaHemoglobinopathyAnemia
05

Safety considerations

Risk of insertional mutagenesis with viral vectorsOff-target effects of CRISPR-Cas9 gene editingVaso-occlusive crisis (VOC) during treatment transitionIron overload from chronic transfusionsMyeloablation-related toxicities from conditioning regimens
06

Interacting drugs

Hydroxyurea

4 more in the full profile.

07

Biomarkers

Fetal hemoglobin (HbF) percentageTotal hemoglobin (Hb) levelsReticulocyte countHemoglobin S (HbS) percentageUnconjugated bilirubinLactate dehydrogenase (LDH)

Beyond the preview

Go deeper on Globin gene (HBB/HBA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Globin gene (HBB/HBA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call